We are live on
!
Find out more
ACM
Advisors Capital Management Portfolio holdings
AUM
$8.58B
1-Year Est. Return
23.43%
This Fund
S&P 500
This Quarter
Est. Return
-3.66%
1 Year Est. Return
+23.43%
3 Year Est. Return
+78.25%
5 Year Est. Return
+87.74%
10 Year Est. Return
+277.95%
AUM
$3.66B
AUM Growth
-$30.5M
(-0.83%)
Cap. Flow
+$168M
Cap. Flow
% of AUM
4.6%
Top 10 Holdings %
Top 10 Hldgs %
20.92%
Holding
456
New
38
Increased
229
Reduced
145
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$25.5M |
| 2 |
SL Green Realty
SLG
|
+$16.8M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$15.9M |
| 4 |
Verizon
VZ
|
+$11M |
| 5 |
Unilever
UL
|
+$10.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$20.4M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$15.6M |
| 3 |
Comcast
CMCSA
|
+$12.7M |
| 4 |
Walmart Inc
WMT
|
+$11.8M |
| 5 |
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
|
+$10M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.46% |
| 2 | Financials | 14.75% |
| 3 | Healthcare | 12.18% |
| 4 | Industrials | 8.14% |
| 5 | Consumer Discretionary | 7.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Iron Mountain
IRM
$36.3B
| $274K | 0.01% |
4,939
-2,709
| -35% | -$129K |
|
377
Synopsys
SNPS
$77.7B
| $274K | 0.01% |
823
+61
| +8% | +$19K |
|
378
Stryker
SYK
$129B
| $274K | 0.01% |
1,023
-177
| -15% | -$45.8K |
|
379
Omnicell
OMCL
$1.64B
| $269K | 0.01% |
2,075
-500
| -19% | -$72.1K |
|
380
Crown Castle
CCI
$32.7B
| $262K | 0.01% |
1,416
-863
| -38% | -$154K |
|
381
Regeneron Pharmaceuticals
REGN
$79.5B
| $262K | 0.01% |
+375
| New | +$237K |
|
382
State Street Health Care Select Sector SPDR ETF
XLV
$42.4B
| $254K | 0.01% |
1,854
+66
| +4% | +$8.74K |
|
383
Tyson Foods
TSN
$20.6B
| $253K | 0.01% |
2,824
-1,743
| -38% | -$159K |
|
384
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$41.2B
| $252K | 0.01% |
7,343
-3,726
| -34% | -$129K |
|
|
MRSH
385
Marsh
MRSH
$92.2B
| $249K | 0.01% |
+1,462
| New | +$230K |
|
|
BNY
386
Bank of New York Mellon
BNY
$108B
| $248K | 0.01% |
4,988
+827
| +20% | +$47K |
|
|
NVO
387
Novo Nordisk
NVO
$203B
| $247K | 0.01% |
+4,444
| New | +$228K |
|
388
Sempra
SRE
$55.1B
| $243K | 0.01% |
+2,892
| New | +$208K |
|
389
Diageo
DEO
$51.6B
| $242K | 0.01% |
1,191
+14
| +1% | +$2.81K |
|
390
Genuine Parts
GPC
$18.3B
| $241K | 0.01% |
1,910
-202
| -10% | -$26.1K |
|
391
Chubb
CB
$137B
| $238K | 0.01% |
1,111
-245
| -18% | -$49.8K |
|
392
iShares Russell 1000 Growth ETF
IWF
$127B
| $235K | 0.01% |
3,380
-184
| -5% | -$12.6K |
|
393
State Street SPDR S&P Dividend ETF
SDY
$23.7B
| $234K | 0.01% |
1,828
+98
| +6% | +$12.4K |
|
394
Dominion Energy
D
$58.8B
| $232K | 0.01% |
2,734
-79
| -3% | -$6.34K |
|
395
Kroger
KR
$35.1B
| $232K | 0.01% |
+4,049
| New | +$201K |
|
396
AutoZone
AZO
$50.1B
| $231K | 0.01% |
+113
| New | +$221K |
|
|
SBR
397
Sabine Royalty Trust
SBR
$1.03B
| $231K | 0.01% |
+4,000
| New | +$211K |
|
398
Cigna
CI
$72.7B
| $230K | 0.01% |
+960
| New | +$225K |
|
399
iShares Core S&P Total US Stock Market ETF
ITOT
$97.1B
| $227K | 0.01% |
+2,248
| New | +$224K |
|
400
Freeport-McMoran
FCX
$95.5B
| $225K | 0.01% |
+4,516
| New | +$200K |
|
Similar funds
NB
IC
PCM
GRQ
MC
DM
FT
QC
Advisors Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Advisors Capital Management held 456 positions worth $3.66B, down 0.83% from $3.69B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Advisors Capital Management deployed $168M of net new capital in Q1 2022, opening 38 new positions and adding to 229 existing holdings. Its largest new stake was SL Green Realty: 213,576 shares worth $17.3M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $20.4M trimmed.
- Advisors Capital Management's largest Q1 2022 buy was SL Green Realty: 213,576 shares worth $17.3M.
- Advisors Capital Management added most to Pfizer in Q1 2022, an estimated $25.5M increase.
- Advisors Capital Management's biggest Q1 2022 reduction was Merck, cutting an estimated $20.4M.
- Advisors Capital Management fully exited Sea Limited in Q1 2022, selling an estimated $6.61M.
- Advisors Capital Management's ten largest holdings make up 21% of its $3.66B portfolio in Q1 2022.
- Advisors Capital Management opened 38 new positions and closed 31 in Q1 2022.
- Advisors Capital Management's portfolio value fell 0.83% quarter-over-quarter to $3.66B.
Based on Advisors Capital Management's 13F filing for Q1 2022, filed 10 May 2022.